Conquering Cancer
With Data
Conquering Cancer
With Data
Guardant Health AMEA is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through blood and tissue tests, real-world data and AI analytics.
About UsUnlocking Insights to Help Find, Treat,
and Monitor Cancer
Today, our tests expand the potential of precision oncology–targeting therapy based on molecular characteristics of the individual’s tumor–by unlocking critical insights into what drives cancer.
Our tests can improve patient outcomes across all stages of cancer, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer.
Serving as an Ally
for Patients
Patients are at the heart of our mission, and they are the inspiration that drives us every day. By connecting with patients and caregivers, we gain insights into the challenges they face at all stages of the journey. Hearing patients’ stories helps us address their real needs in meaningful ways.
Our Products
Our blood and tissue tests provide insights that can improve patient outcomes throughout the cancer journey.
Guiding treatment decisions in advanced cancer and recurrence monitoring in early-stage cancer.
Explore Guardant Complete
